Envoy Medical Inc (COCH)

Envoy Medical, Inc. is a healthcare company focused on hearing health technologies across a range of hearing loss needs. The company develops medical devices intended for patients and providers in the hearing industry, including personal sound amplification products, hearing aids, the Esteem fully implanted active middle ear implant, auditory osseointegrated implants, and the Acclaim cochlear implant. Formerly known as Envoy Medical Corporation, the company adopted its current name in September 2023. Envoy Medical was founded in 1995 and is based in White Bear Lake, Minnesota. Its common stock is listed on the NASDAQ exchange under the symbol COCH.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-COCH
$0.58
-18.4% Downside
Overvalued
$2
179.7% Upside
Bargain
Weak
0.0%
November 18, 2026
14.8x
264.8x
55.225 M
35.947 M
1.4%
56.0%
-20.2
76.3%
Valuation • Fair Value

Envoy Medical Inc (NASDAQ-COCH) Fair Value by Valuation Model

Review the available estimates for Envoy Medical Inc (NASDAQ-COCH), including EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$0.58

Estimated downside of 18.4% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

EPV Fair Value

$0.50

Earnings power value estimate.

Comps Fair Value

$0.60

Comparable-company valuation reference.

Analyst Price Target

$2

Analysts imply upside of 179.7%.

How to read these valuation models

Use the 5 available valuation references for Envoy Medical Inc (NASDAQ-COCH) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Envoy Medical Inc (NASDAQ-COCH)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

207 K

Current operating scale indicator.

Revenue Forecast

250 K

Forward revenue estimate.

EBITDA

-23.128 M

Current operating profitability reference.

EBITDA Forecast

-25 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Envoy Medical Inc (NASDAQ-COCH) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Envoy Medical Inc (NASDAQ-COCH)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

3

Weak quality score that deserves closer review.

Beneish M-Score

-3.83

No elevated caution signal from this screen.

Altman Z-Score

-20.2

Lower score that deserves closer risk review.

FCF / Net Income

76.3%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Envoy Medical Inc (NASDAQ-COCH). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Envoy Medical Inc (NASDAQ-COCH)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 18, 2026

Days to Earnings

57

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Envoy Medical Inc (NASDAQ-COCH), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Envoy Medical Inc (NASDAQ-COCH) Stock Forecast & Technical Outlook

Review Envoy Medical Inc (NASDAQ-COCH) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Envoy Medical Inc (NASDAQ-COCH) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Envoy Medical Inc (NASDAQ-COCH) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Buy

The daily technical read for Envoy Medical Inc (NASDAQ-COCH) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for Envoy Medical Inc (NASDAQ-COCH) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Envoy Medical Inc (NASDAQ-COCH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Envoy Medical Inc (NASDAQ-COCH)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Envoy Medical Inc (NASDAQ-COCH) has a Strong Buy consensus, with 2 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 2
Hold 0
Sell 0
FAQ Fast Investor Answers

Envoy Medical Inc (NASDAQ-COCH) Stock FAQ

Data-supported answers about Envoy Medical Inc (NASDAQ-COCH), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.58
Estimated downside 18.4%
Valuation Rating
Overvalued
Estimated downside of 18.4%
Analyst Target
$2
Implied upside 179.7%
Financial Health
Weak
Current financial-health read

The current fair value estimate for Envoy Medical Inc (NASDAQ-COCH) is $0.58. This implies an estimated downside of 18.4% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 18.4% versus the current market price.

The available analyst price target for Envoy Medical Inc (NASDAQ-COCH) is $2. The analyst target implies estimated upside of 179.7%.

The current financial health read for Envoy Medical Inc (NASDAQ-COCH) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Envoy Medical Inc (NASDAQ-COCH) is November 18, 2026.

The latest available data indicates no current dividend yield for Envoy Medical Inc (NASDAQ-COCH).

The current market capitalization listed for Envoy Medical Inc is 55.225 M.

The current enterprise value listed for Envoy Medical Inc is 35.947 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Envoy Medical Inc is NASDAQ-COCH, and the stock is listed on NASDAQ.

Envoy Medical Inc (NASDAQ-COCH) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Envoy Medical Inc is 1.4%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Envoy Medical Inc is 56.0%. Free float helps investors understand how much of the share base is available for public trading.